VC

Investor profile

Tramway Venture Partners

United StatesSouthwest USNew MexicoHealthtechBio/PharmaDeep TechAI/ML

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Tramway Venture Partners focuses on building disruptive life science companies at the intersection of physical sciences, information technology, and healthcare. The firm leverages New Mexico's technology-rich environment, including partnerships with three national research laboratories (Los Alamos, Sandia, Air Force Research Laboratory) and three research universities. Tramway typically invests in the first institutional round after incubators and angel investors, targeting companies with outstanding management teams, significant intellectual property, and clear market strategies. The firm seeks opportunities that exploit convergent technologies and require less than $30 million in total capital to exit. Tramway positions itself to capitalize on the state's world-class research institutions and untapped potential in 'out-of-the-way' places where opportunities abound, particularly as venture capital shifts focus inland from traditional coastal hubs.

Recent investments

CompanyRoundSizeDate
Nob Hill TherapeuticsSeries A2024-08-06
Circular GenomicsSeries A2024-01-11
Circular GenomicsSeed2021-12-08
Daisy GenomicsSeries B2021-10-18
Vitazi.aiunknown2021-07
BennuBiounknown
Breezy Medunknown
Epistemixunknown
WaveDyn Visionunknown
Yeeo Eco-Safeunknown

Frequent co-investors

VC firmDeals together
Cottonwood Technology Fund3
Mountain Group Partners2
TCA Venture Group1
New Mexico Angels1
Tullis Health Investors1
Cultivation Capital1

Fit check

Is Tramway Venture Partners a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit